Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling long-term diabetes control without the burden of full immunosuppression.

A n international team of scientists has made an advancement in diabetes research by successfully 3D printing functional Langerhans islands (human islets) using a novel bioink. In laboratory tests ...

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment. May 19, 2025 3:10 PM ET Sana Biotechnology, Inc. (SANA) Stock SANA 20 Comments. Terry Chrisomalis.

Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch more than 5 years after islet transplantation Histological data confirmation of ...

Sana Biotechnology’s genetically engineered pancreatic islet cells controlled glucose levels for six months in a diabetic primate without requiring insulin or immunosuppression, according to new ...

Sana's first-in-human study shows HIP technology allows islet cells to avoid immune rejection and produce insulin without immunosuppression. Reliance on initial results: The press release heavily ...

CHICAGO — A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a ...

Despite biologic plausibility, systematic testing for SARS-CoV-2 and type 1 diabetes in children in this prospective, multinational cohort did not show that Covid-19 precipitated type 1 diabetes.

Scientists developed a multi-organoid system from human induced pluripotent stem cells (hiPSCs) to simulate human liver-islet axis in normal and T2DM.